| 51 |
21243324 | High EGFR mRNA expression is a prognostic factor for reduced survival in pancreatic cancer after gemcitabine-based adjuvant chemotherapy. | 2011 Mar |
5 |
| 52 |
21485840 | EGFR targeted PLGA nanoparticles using gemcitabine for treatment of pancreatic cancer. | 2011 Feb |
2 |
| 53 |
21498735 | Does erlotinib restore chemosensitivity to chemotherapy in pancreatic cancer? A case series. | 2011 Mar |
4 |
| 54 |
21850211 | Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells through Downregulation of Akt. | 2011 |
3 |
| 55 |
21970876 | Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells. | 2011 Nov 8 |
2 |
| 56 |
19536777 | Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer. | 2010 Jan 1 |
2 |
| 57 |
20213764 | Concurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer. | 2010 May |
1 |
| 58 |
20606093 | Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205. | 2010 Aug 1 |
1 |
| 59 |
20726858 | Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer. | 2010 Nov |
2 |
| 60 |
20824720 | Molecular predictors of outcome in a phase 3 study of gemcitabine and erlotinib therapy in patients with advanced pancreatic cancer: National Cancer Institute of Canada Clinical Trials Group Study PA.3. | 2010 Dec 15 |
1 |
| 61 |
20961434 | Complete response in gallbladder cancer to erlotinib plus gemcitabine does not require mutation of the epidermal growth factor receptor gene: a case report. | 2010 Oct 20 |
1 |
| 62 |
21087480 | Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas. | 2010 Nov 18 |
1 |
| 63 |
22966286 | Antitumor activity of erlotinib in combination with gemcitabine in in vitro and in vivo models of KRAS-mutated pancreatic cancers. | 2010 Mar |
3 |
| 64 |
19454812 | Combining epidermal growth factor receptor inhibitors and radiation therapy in pancreatic cancer: small step or giant leap? | 2009 May 18 |
1 |
| 65 |
18418211 | New directions in the management of advanced pancreatic cancer: a review. | 2008 Jun |
1 |
| 66 |
18505070 | Present treatment and future expectations in advanced pancreatic cancer. | 2008 Mar-Apr |
2 |
| 67 |
18698032 | The combination of epidermal growth factor receptor inhibitors with gemcitabine and radiation in pancreatic cancer. | 2008 Aug 15 |
2 |
| 68 |
18980967 | Improving gemcitabine-mediated radiosensitization using molecularly targeted therapy: a review. | 2008 Nov 1 |
1 |
| 69 |
17146438 | Role of epidermal growth factor receptor degradation in gemcitabine-mediated cytotoxicity. | 2007 May 17 |
9 |
| 70 |
17555368 | Her signaling in pancreatic cancer. | 2007 Jun |
2 |
| 71 |
17686445 | How could pharmacogenomics help improve patient survival? | 2007 Aug |
1 |
| 72 |
17827452 | Antimetabolite radiosensitizers. | 2007 Sep 10 |
3 |
| 73 |
17845978 | [Gemcitabine and non small-cell lung cancer]. | 2007 |
1 |
| 74 |
16424033 | Synergistic effects of gemcitabine and gefitinib in the treatment of head and neck carcinoma. | 2006 Jan 15 |
3 |
| 75 |
16621676 | Tyrosine kinase inhibitors and gemcitabine: new treatment options in pancreatic cancer? | 2006 Feb-Apr |
3 |
| 76 |
16026649 | Induction of apoptosis in tumor-associated endothelial cells and therapy of orthotopic human pancreatic carcinoma in nude mice. | 2005 Jul |
4 |
| 77 |
16288027 | Simultaneous inhibition of EGFR, VEGFR, and platelet-derived growth factor receptor signaling combined with gemcitabine produces therapy of human pancreatic carcinoma and prolongs survival in an orthotopic nude mouse model. | 2005 Nov 15 |
1 |
| 78 |
15226328 | Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II Trial. | 2004 Jul 1 |
2 |
| 79 |
12429651 | Blockade of the epidermal growth factor receptor signaling inhibits angiogenesis leading to regression of human renal cell carcinoma growing orthotopically in nude mice. | 2002 Nov |
2 |
| 80 |
10815919 | Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms. | 2000 May |
1 |
| 81 |
10850439 | Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma. | 2000 Jun 1 |
1 |